Recurrence	0	9
of	11	12
Helicobacter	14	25
pylori	27	32
infection	34	42
1	44	44
year	46	49
after	51	55
successful	57	66
treatment	68	76
:	77	77
prospective	79	89
cohort	91	96
study	98	102
in	104	105
the	107	109
Republic	111	118
of	120	121
Yemen	123	127
.	128	128

To	130	131
investigate	133	143
the	145	147
prevalence	149	158
of	160	161
Helicobacter	163	174
pylori	176	181
infection	183	191
in	193	194
dyspeptic	196	204
patients	206	213
in	215	216
the	218	220
Republic	222	229
of	231	232
Yemen	234	238
and	240	242
the	244	246
recurrence	248	257
rate	259	262
1	264	264
year	266	269
after	271	275
apparently	277	286
successful	288	297
eradication	299	309
.	310	310

A	312	312
total	314	318
of	320	321
275	323	325
patients	327	334
with	336	339
chronic	341	347
dyspepsia	349	357
seen	359	362
in	364	365
one	367	369
clinic	371	376
were	378	381
enrolled	383	390
.	391	391

Gastric	393	399
biopsies	401	408
were	410	413
obtained	415	422
at	424	425
endoscopy	427	435
and	437	439
H	441	441
.	442	442
pylori	444	449
infection	451	459
was	461	463
diagnosed	465	473
using	475	479
the	481	483
rapid	485	489
urease	491	496
test	498	501
.	502	502

Patients	504	511
with	513	516
H	518	518
.	519	519
pylori	521	526
infection	528	536
were	538	541
given	543	547
either	549	554
clarithromycin	556	569
or	571	572
metronidazole	574	586
-	587	587
based	588	592
triple	594	599
therapy	601	607
.	608	608

Six	610	612
weeks	614	618
later	620	624
H	626	626
.	627	627
pylori	629	634
status	636	641
was	643	645
assessed	647	654
using	656	660
the	662	664
C	666	666
-	667	667
urea	668	671
breath	673	678
test	680	683
(	685	685
C	686	686
-	687	687
UBT	688	690
)	691	691
.	692	692

Those	694	698
who	700	702
were	704	707
negative	709	716
for	718	720
H	722	722
.	723	723
pylori	725	730
had	732	734
a	736	736
further	738	744
C	746	746
-	747	747
UBT	748	750
after	752	756
1	758	758
year	760	763
to	765	766
establish	768	776
the	778	780
recurrence	782	791
rate	793	796
.	797	797

The	799	801
prevalence	803	812
of	814	815
H	817	817
.	818	818
pylori	820	825
infection	827	835
at	837	838
entry	840	844
to	846	847
the	849	851
study	853	857
was	859	861
82	863	864
.	865	865
2	866	866
%	867	867
[	869	869
95	870	871
%	872	872
confidence	874	883
interval	885	892
(	894	894
CI	895	896
)	897	897
78	899	900
-	901	901
87	902	903
%	904	904
]	905	905
.	906	906

The	908	910
overall	912	918
eradication	920	930
rate	932	935
6	937	937
weeks	939	943
after	945	949
treatment	951	959
was	961	963
49	965	966
.	967	967
1	968	968
%	969	969
(	971	971
95	972	973
%	974	974
CI	976	977
42	979	980
.	981	981
6	982	982
-	983	983
55	984	985
.	986	986
6	987	987
%	988	988
)	989	989
by	991	992
intention	994	1002
-	1003	1003
to	1004	1005
-	1006	1006
treat	1007	1011
analysis	1013	1020
,	1021	1021
and	1023	1025
60	1027	1028
%	1029	1029
(	1031	1031
95	1032	1033
%	1034	1034
CI	1036	1037
53	1039	1040
-	1041	1041
67	1042	1043
%	1044	1044
)	1045	1045
by	1047	1048
per	1050	1052
-	1053	1053
protocol	1054	1061
analysis	1063	1070
.	1071	1071

Recurrence	1073	1082
rate	1084	1087
of	1089	1090
H	1092	1092
.	1093	1093
pylori	1095	1100
infection	1102	1110
at	1112	1113
1	1115	1115
year	1117	1120
was	1122	1124
34	1126	1127
%	1128	1128
(	1130	1130
95	1131	1132
%	1133	1133
CI	1135	1136
14	1138	1139
-	1140	1140
45	1141	1142
%	1143	1143
)	1144	1144
and	1146	1148
the	1150	1152
only	1154	1157
predictor	1159	1167
of	1169	1170
recurrence	1172	1181
was	1183	1185
an	1187	1188
excess	1190	1195
delta	1197	1201
C	1203	1203
-	1204	1204
UBT	1205	1207
value	1209	1213
less	1215	1218
than	1220	1223
3	1225	1225
.	1226	1226
5	1227	1227
per	1229	1231
million	1233	1239
but	1241	1243
equal	1245	1249
to	1251	1252
or	1254	1255
greater	1257	1263
than	1265	1268
2	1270	1270
.	1271	1271
5	1272	1272
per	1274	1276
million	1278	1284
at	1286	1287
6	1289	1289
weeks	1291	1295
after	1297	1301
treatment	1303	1311
(	1313	1313
odds	1314	1317
ratio	1319	1323
2	1325	1325
.	1326	1326
28	1327	1328
;	1329	1329
95	1331	1332
%	1333	1333
CI	1335	1336
1	1338	1338
.	1339	1339
17	1340	1341
-	1342	1342
4	1343	1343
.	1344	1344
44	1345	1346
;	1347	1347
P	1349	1349
=	1351	1351
0	1353	1353
.	1354	1354
028	1355	1357
)	1358	1358
.	1359	1359

The	1361	1363
prevalence	1365	1374
of	1376	1377
H	1379	1379
.	1380	1380
pylori	1382	1387
infection	1389	1397
in	1399	1400
dyspeptic	1402	1410
patients	1412	1419
in	1421	1422
Yemen	1424	1428
is	1430	1431
very	1433	1436
high	1438	1441
,	1442	1442
the	1444	1446
eradication	1448	1458
rate	1460	1463
with	1465	1468
standard	1470	1477
triple	1479	1484
therapy	1486	1492
was	1494	1496
unsatisfactory	1498	1511
probably	1513	1520
because	1522	1528
of	1530	1531
widespread	1533	1542
bacterial	1544	1552
resistance	1554	1563
due	1565	1567
to	1569	1570
unrestricted	1572	1583
antibiotic	1585	1594
use	1596	1598
.	1599	1599

The	1601	1603
recurrence	1605	1614
rate	1616	1619
of	1621	1622
infection	1624	1632
at	1634	1635
1	1637	1637
year	1639	1642
was	1644	1646
high	1648	1651
,	1652	1652
as	1654	1655
a	1657	1657
result	1659	1664
of	1666	1667
recrudescence	1669	1681
of	1683	1684
incompletely	1686	1697
eradicated	1699	1708
organisms	1710	1718
rather	1720	1725
than	1727	1730
reinfection	1732	1742
.	1743	1743
